scholarly journals Antihypertensive Medication Use and Blood Pressure Control: A Community-Based Cross-Sectional Survey (ON-BP)

2008 ◽  
Vol 21 (11) ◽  
pp. 1210-1215 ◽  
Author(s):  
N. H. McInnis ◽  
G. Fodor ◽  
M. Moy Lum-Kwong ◽  
F. H. H. Leenen
BMJ Open ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. e037618
Author(s):  
Remya Sudevan ◽  
Damodaran Vasudevan ◽  
Manu Raj ◽  
Rajesh Thachathodiyl ◽  
Maniyal Vijayakumar ◽  
...  

ObjectivesThe primary objective of the study was to report the compliance to secondary prevention strategies for coronary artery disease (CAD), such as smoking cessation, weight management, low-density lipoprotein (LDL) cholesterol control, blood pressure control, glycaemic control, physical activity and cardiovascular drug therapy from a resource-limited setting.DesignAnalytical cross-sectional survey with data collection using questionnaire administered by study personnel.SettingInstitutional—two tertiary care hospitals and two cardiology clinics.ParticipantsPatients in the age group of 30–80 years with documented CAD with a minimum of 1 year and a maximum of 6 years of follow-up after diagnosis.Main outcome measuresThe main outcome measures were the prevalence of individual compliance to secondary prevention strategies for CAD such as smoking cessation, weight management, LDL cholesterol control, blood pressure control, glycaemic control, physical activity and cardiovascular drug therapy. The secondary outcomes were the association of secondary prevention strategies with age, sex, domicile, socioeconomic status, insurance and type of treatment.ResultsWe recruited a total of 1206 patients among whom 879 (72.9%) were males. The median age of patients was 62 (14) years. The compliance to smoking cessation was 93.86% (95% CI 91.66% to 96.06%), ideal body mass index was 63.76% (95% CI 61.05% to 66.47%), blood pressure control was 65.11% (95% CI 62.42% to 67.80%), LDL compliance was 36.50% (95% CI 33.18% to 39.82%), diabetes control was 51.23% (95% CI 46.10% to 56.36%) and adequate physical activity was 39.22% (95% CI 36.46% to 41.98%)respectively. Reported compliance for cardiovascular drugs therapy was 96% for antiplatelets, 89.4% for statins, 68.2% for beta blockers, 37.7% for renin angiotensin aldosterone system blockers, 81.28% for oral hypoglycaemic agents and 22% for insulin therapy.ConclusionCompliance to secondary prevention strategies for CAD in resource limited settings are moderate. This needs further improvement for better outcomes related to CAD in future.


2015 ◽  
Vol 29 (1) ◽  
pp. 104-113 ◽  
Author(s):  
Giselle Sarganas ◽  
Hildtraud Knopf ◽  
Daniel Grams ◽  
Hannelore K. Neuhauser

Author(s):  
Kendra D Sims ◽  
Ellen Smit ◽  
George David Batty ◽  
Perry W Hystad ◽  
Michelle C Odden

Abstract Background Associations between multiple forms of discrimination and blood pressure control in older populations remain unestablished. Methods Participants were 14582 non-institutionalized individuals (59% women) in the Health and Retirement Study aged at least 51 years (76% Non-Hispanic White, 15% Non-Hispanic Black, 9% Hispanic/Latino). Primary exposures included the mean frequency of discrimination in everyday life, intersectional discrimination (defined as marginalization ascribed to more than one reason), and the sum of discrimination over the lifespan. We assessed whether discrimination was associated with change in measured hypertension status (N=14582) and concurrent medication use among reported hypertensives (N=9086) over four years (2008-2014). Results There was no association between the frequency of everyday discrimination and change in measured hypertension. Lifetime discrimination was associated with higher odds of hypertension four years later among men (OR: 1.21, 95% CI: 1.08, 1.36) but not women (OR: 0.98, 95% CI: 0.86, 1.13). Only among men, everyday discrimination due at least two reasons was associated with a 1.44 (95% CI: 1.03, 2.01)-fold odds of hypertension than reporting no everyday discrimination; reporting intersectional discrimination was not associated with developing hypertension among women (OR: 0.91, 95% CI: 0.70, 1.20). All three discriminatory measures were inversely related to time-averaged antihypertensive medication use, without apparent gender differences (e.g., OR for everyday discrimination-antihypertensive use associations: 0.85, 95% CI: 0.77, 0.94)). Conclusions Gender differences in marginalization may more acutely elevate hypertensive risk among older men than similarly aged women. Experiences of discrimination appear to decrease the likelihood of antihypertensive medication use among older adults overall.


Sign in / Sign up

Export Citation Format

Share Document